1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Leukemia, Promyelocytic, Acute in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 10 (90.91) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lohmeyer, M; Workman, P | 1 |
| Coburn, JP; Eggleton, P; Ghebrehiwet, B; Sastry, KN; Tauber, AI; Zaner, KS | 1 |
| Evangelista, V; Locati, M; Luini, W; Mantovani, A; Sozzani, S; Zhou, D | 1 |
| Rola-Pleszczynski, M; Stankova, J | 1 |
| Dupuis, G; Müller, E; Rola-Pleszczynski, M; Turcotte, S | 1 |
| Dive, C; Watson, JV; Workman, P | 1 |
| Donaldson, J; Lohmeyer, M; Workman, P | 1 |
| Record, M; Snyder, F; Vallari, DS | 1 |
| Austinhirst, R; Snyder, F; Vallari, DS | 1 |
| Chap, H; Lumb, RH; Pool, GL; Record, M; Ribbes, G; Terce, F | 1 |
| Böhme, E; Schmidt, HH; Seifert, R | 1 |
11 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Cycle; Cell Division; Cell Membrane; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Mammary Neoplasms, Experimental; Mice; Phospholipid Ethers; Platelet Activating Factor; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 1995 |
Characterization of the human neutrophil C1q receptor and functional effects of free ligand on activated neutrophils.
Topics: Antibodies; Blotting, Western; Carrier Proteins; Cell Differentiation; Cell Membrane; Complement C1q; Humans; Hyaluronan Receptors; In Vitro Techniques; Kinetics; Leukemia, Promyelocytic, Acute; Macrophage-1 Antigen; Membrane Glycoproteins; Mitochondrial Proteins; Molecular Weight; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Receptors, Complement; Superoxides; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Up-Regulation | 1994 |
Rapid induction of arachidonic acid release by monocyte chemotactic protein-1 and related chemokines. Role of Ca2+ influx, synergism with platelet-activating factor and significance for chemotaxis.
Topics: Arachidonic Acid; Calcimycin; Calcium; Cell Line; Chemokine CCL2; Chemotactic Factors; Chemotaxis, Leukocyte; Cytokines; Egtazic Acid; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Pertussis Toxin; Platelet Activating Factor; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1994 |
Differentiation-dependent modulation of TNF production by PAF in human HL-60 myeloid leukemia cells.
Topics: Calcitriol; Calcium; Cell Differentiation; Humans; Leukemia, Promyelocytic, Acute; Platelet Activating Factor; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
Human PAF receptor gene expression: induction during HL-60 cell differentiation.
Topics: Blotting, Northern; Calcitriol; Calcium; Cell Differentiation; Cell Line; DNA Probes; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Macrophages; Open Reading Frames; Platelet Activating Factor; Platelet Membrane Glycoproteins; Poly A; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA; RNA, Messenger | 1991 |
Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Division; Cell Membrane Permeability; Flow Cytometry; Furans; Humans; Hydrogen-Ion Concentration; Leukemia, Promyelocytic, Acute; Mammary Neoplasms, Animal; Mice; Phospholipid Ethers; Platelet Activating Factor; Time Factors; Triazoles; Tumor Cells, Cultured | 1991 |
Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells.
Topics: Antineoplastic Agents; Azepines; Calcium; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Furans; Humans; Leukemia, Promyelocytic, Acute; Phospholipid Ethers; Platelet Activating Factor; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 1991 |
Conversion of alkylacetylglycerol to platelet-activating factor in HL-60 cells and subcellular localization of the mediator.
Topics: Cell Line; Diacylglycerol Cholinephosphotransferase; Glyceryl Ethers; Humans; Leukemia, Promyelocytic, Acute; Phospholipids; Platelet Activating Factor; Subcellular Fractions; Tritium | 1990 |
Development of specific functionally active receptors for platelet-activating factor in HL-60 cells following granulocytic differentiation.
Topics: Acetylglucosaminidase; Binding, Competitive; Cell Differentiation; Cytochalasin B; Dimethyl Sulfoxide; Granulocytes; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Cells, Cultured | 1990 |
PAF-acether transfer activity in HL-60 cells is induced during differentiation.
Topics: Bucladesine; Cell Differentiation; Cell Line; Chromatography, Gel; Cytosol; Dimethyl Sulfoxide; Granulocytes; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Macrophages; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetradecanoylphorbol Acetate | 1990 |
Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor and leukotriene B4.
Topics: Bucladesine; Calcitriol; Canavanine; Cell Line; Humans; In Vitro Techniques; Kinetics; Leukemia, Promyelocytic, Acute; Leukotriene B4; Luminescence; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nitric Oxide; Platelet Activating Factor | 1989 |